Warning: This security is no longer trading.
Seattle Genetics completed its tender offer for all common shares of Cascadian Therapeutics
Cascadian Therapeutics, Inc. (CASC): Price and Financial Metrics
CASC Price/Volume Stats
| Current price | $9.98 | 52-week high | $10.21 |
| Prev. close | $10.02 | 52-week low | $3.18 |
| Day low | $9.98 | Volume | 2,000 |
| Day high | $9.98 | Avg. volume | 1,092,996 |
| 50-day MA | $7.35 | Dividend yield | N/A |
| 200-day MA | $4.78 | Market Cap | 505.19M |
CASC Stock Price Chart Interactive Chart >
Cascadian Therapeutics, Inc. (CASC) Company Bio
Cascadian Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of cancer. The company was founded in 1985 and is based in Seattle, Washington.
CASC Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...